THE EFFECT OF ADDING AMANTADINE TO OPTIMUM L-DOPA DOSAGE IN PARKINSON'S SYNDROME
- 29 January 2009
- journal article
- clinical trial
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 49 (2) , 245-251
- https://doi.org/10.1111/j.1600-0404.1973.tb01296.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- TREATMENT OF PARKINSON'S SYNDROME WITH L-DOPA A DOUBLE BLIND STUDYActa Neurologica Scandinavica, 2009
- Amantadine and levodopa in the treatment of Parkinson's diseaseClinical Pharmacology & Therapeutics, 1972
- TREATMENT OF PARKINSON'S DISEASE WITH AMANTADINE AND LEVODOPA: A One-year StudyThe Lancet, 1971
- TREATMENT OF PARKINSONISM WITH L-DOPA AND AMANTADINEThe Lancet, 1970
- COMBINED TREATMENT OF PARKINSONISM WITH L-DOPA AND AMANTADINEThe Lancet, 1970
- COMBINED TREATMENT OF PARKINSONISM WITH L-DOPA AND AMANTADINEThe Lancet, 1970
- AMANTADINE FOR PARKINSON'S DISEASEThe Lancet, 1970
- CONTROLLED TRIAL OF AMANTADINE HYDROCHLORIDE IN PARKINSON'S DISEASEThe Lancet, 1970
- Amantadine in the Treatment of Parkinson's DiseaseJAMA, 1969
- ParkinsonismNeurology, 1967